Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference Pharmaceutical Investing
CLASS ACTION UPDATE for ABBV, MYPS and CS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Aurinia Pharmaceuticals to Release First Quarter 2022 Financial and Operational Results on May 10, 2022 Pharmaceutical Investing
Rosen, A LEADING LAW FIRM, Encourages AbbVie Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
CLASS ACTION UPDATE for LCID, IBM and AUPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
ROSEN, Leading Investor Counsel, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Reminds Aurinia Pharmaceuticals Inc. Investors of Class Action and Encourages Investors to Contact the Firm Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Bausch Health Companies Investigation Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for AbbVie, Inc. Investors in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation Pharmaceutical Investing
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference Pharmaceutical Investing
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
